Anthem Biosciences - About the company
Anthem Biosciences is a series A company based in Bengaluru (India), founded in 2006 by , and . It operates as a Contract research and innovation service provider specializes in integrated drug discovery, process development, and scale-up services. Anthem Biosciences has raised $35.7M in funding from and True North, with a current valuation of 鈧�7,450颁谤. The company has 166 active competitors, including 15 funded and 50 that have exited. Its top competitors include companies like Abzena, Patheon and Syngene.
Company Details
Contract research and innovation service provider specializes in integrated drug discovery, process development, and scale-up services. It offers a range of services, include In Vitro and In Vivo Efficacy Testing, ADME Toxicology, Process & Medicinal Chemistry, Custom Synthesis, cGMP Manufacturing, Quality & Regulatory Support, Assay Biology, In Vivo Pharmacology, Analytical, Antibody Drug Conjugates, and Green Chemistry Initiatives.
- Website
- Social
- Email ID
- @anthembio.com
- Phone Number
- +91
Legal entities associated with Anthem Biosciences
Anthem Biosciences is associated with 3 legal entities given below:
Legal Entity Name | Date of incorporation | Revenue | Net Profit | Employee Count |
|---|---|---|---|---|
Nov 18, 2009 | $3.62M (as on Mar 31, 2022) | 310 | 261 | |
Jun 10, 1991 | $13.6M (as on Mar 31, 2017) | 615 | 501 | |
Jun 12, 2006 | $179M (as on Mar 31, 2024) | 691 | 969 |
Get your free copy of Anthem Biosciences's company profile
Anthem Biosciences's funding and investors
Anthem Biosciences has raised a total funding of $35.7M over 4 rounds. Its first funding round was on May 29, 2008. Its latest funding round was a Series A round on Mar 01, 2021 for $33.4M. 1 investor participated in its latest round, which include Global PE Alliance, True North, Faering Capital and .
Anthem Biosciences has 5 institutional investors including , True North and . True North is the largest institutional investor in Anthem Biosciences. Muppala Raju and 2 others are Angel Investors in Anthem Biosciences.
Here is the list of recent funding rounds of Anthem Biosciences:
Date of funding | Funding Amount | Round Name | Post money valuation | Revenue multiple | Investors |
|---|---|---|---|---|---|
Mar 01, 2021 | $33.4M | Series A | 7400227 | 6365984 | |
Nov 14, 2016 | $1.75M | Seed | 2552781 | 8004415 | |
2012 | Undisclosed | Grant (prize money) | 9617 | 7466 |
Access funding benchmarks and valuations. Sign up today!View details of Anthem Biosciences's funding rounds and investors
Anthem Biosciences's valuation details
Anthem Biosciences is valued at $997M as per the latest available filings. Here is Anthem Biosciences's valuation trend over time:
Date | Valuation |
|---|---|
Apr 21 | $997M |
Apr 21 | 511 |
Mar 21 | 122 |
Mar 17 | 449 |
Nov 16 | 352 |
May 08 | 167 |
See how Anthem Biosciences's valuation has changed over time. Sign up today!Anthem Biosciences's founders and board of directors
The founders of Anthem Biosciences are , and . is the CEO of Anthem Biosciences.
View details of Anthem Biosciences's Founder profiles and Board Members
Anthem Biosciences's Competitors and alternates
Top competitors of Anthem Biosciences include Abzena, Patheon and Syngene. Here is the list of Top 10 competitors of Anthem Biosciences, ranked by 秘密研究所 score :
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Overall Rank | Company Details | Short Description | Total Funding | Investors | 秘密研究所 Score |
|---|---|---|---|---|---|
1st | 2006, Bengaluru (India), Series A | Contract research and innovation service provider specializes in integrated drug discovery, process development, and scale-up services | $35.7M | Global PE Alliance, True North听&补尘辫;听 | 69/100 |
2nd |  Abzena 2001, Cambridge (United Kingdom), Acquired | Provider of antibody discovery, cell line development, and bio analytics services | $67.1M | 72/100 | |
3rd | Patheon 1974, Durham (United States), Acquired | Commercial manufacturing and pharmaceutical development services for biopharmaceutical industry | $141M | Frazier Healthcare Partners, 听&补尘辫;听 | 72/100 |
4th | Provider of contract research and manufacturing services for both small molecules and biologics | $85.9M | Goldman Sachs, Morgan Stanley听&补尘辫;听 | 71/100 | |
5th |  Piramal Group 1984, Mumbai (India), Public | Multinational conglomerate with diverse interests in Pharma, Financial Services and Real Estate | - | 69/100 | |
6th |  Panacea Biotec 1984, Ambala (India), Public | Developer of biosimilars, vaccines and natural products | - | 68/100 | |
7th | Maravai Life Sciences 2014, San Diego (United States), Public | Provides enabling tools and services in the life sciences research and bio-production industries | - | 67/100 | |
8th | Grand River Aseptic Manufacturing 2010, Grand Rapids (United States), Acquired | Sterile Parenterals CDMO | $16.9M | 66/100 | |
9th |  Insud Pharma 1977, Madrid (Spain), Funding Raised | Developer and manufacturer of finished formulations, APIs and monoclonal antibodies | - | 60/100 | |
10th | LakePharma 2009, Belmont (United States), Acquired | Provider of drug discovery on molecular biology, viral vectors and cell & protein engineering | $30M | 58/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Anthem Biosciences's competitors? Click to see the top ones
Anthem Biosciences's Latest cap tables and shareholding
Founders (largest shareholder) own 78.84%, Funds own 4.68%, Enterprises own 3.77% and Angels own 0.00%. The net worth of Anthem Biosciences's founders is INR 5,870Cr as of Apr 08, 2021.
Shareholders Name | Post Round Holding % | Net worth | Cumulative investment | Realised returns | Unrealised returns | Return multiple |
|---|---|---|---|---|---|---|
Founder | 78.84% | 5,870Cr | 5190705 | 4450876 | 8728474 | 2028620 |
3387820 | 6589436 | 6008369 | 9252245 | 3569352 | 5058359 | |
6940227 | 4642517 | 9859985 | 8484315 | 4165973 | 9055383 | |
3976714 | 8379949 | 1900354 | 6382943 | 3803521 | 3368830 | |
Fund | 4.68% | 348Cr | 5270 | 9718 | 8954 | 7673 |
857 | 174 | 483 | 645 | 847 | 841 | |
Enterprise | 3.77% | 280Cr | 242 | 100 | 815 | 528 |
Angel | - | 0 | 0 | 0 | 0 | 0 |
0 | 0 | 0 | 0 | 0 | 0 | |
Other People | 12.71% | 947Cr | 5035744 | 1915818 | 9463386 | 2410882 |
Total | 100.00% | 7,450Cr | 4247249 | 3434398 | 2017496 | 7199432 |
To unlock detailed Cap Table of Anthem Biosciences Sign up today!Notes: The column Net Worth represents the net worth of investments made by that entity, as per the latest cap table.
DisclaimerView more details of Anthem Biosciences's Shareholding
Anthem Biosciences's Investments and acquisitions
Anthem Biosciences has made no investments or acquisitions yet.
Reports related to Anthem Biosciences
Here is the latest report on Anthem Biosciences's sector:
View
News related to Anthem Biosciences
Media has covered Anthem Biosciences for a total of 3 events in the last 1 year.
鈥�
鈥�
鈥�
鈥�
鈥�
鈥�
鈥�
鈥�
鈥�
鈥�
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Our Lite Plan Awaits you - Its Free!
Sign up now to unlock full access to curated data
4M+ Companies- 212K+ Investors
- 580K+ Funding Rounds
- 207K+ Acquisitions
- 2.9K+ Sectors
- 57K+ Business Models
Are you a Founder ?
FAQ's about Anthem Biosciences
Explore our recently published companies
- WeAttach Technologies - Noida based, 2015 founded, Unfunded company
- Perfect Vodka - Jupiter based, 1864 founded, Funding Raised company
- Netive VMS - Brighton based, 2003 founded, Seed company
- iPaydayLoans - Hacienda Heights based, 2022 founded, Unfunded company
- FideliumTech - Austin based, 2008 founded, Funding Raised company
- Pltutoblues - Kanpur based, 2016 founded, Unfunded company
